Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Novel Home Care Device for High-Risk Diabetic Patients (TempTouchRM)
This study is currently recruiting participants.
Verified by Diabetica Solutions Inc., July 2007
Sponsors and Collaborators: Diabetica Solutions Inc.
National Institutes of Health (NIH)
Information provided by: Diabetica Solutions Inc.
ClinicalTrials.gov Identifier: NCT00500175
  Purpose

More than half of all lower extremity amputations are in persons with diabetes. These patients suffer from severe, diabetes-induced, peripheral, sensory neuropathy and, thus they frequently do not protect their feet from repetitive shear stress or traumatic episodes and ulceration often ensues. We have previously shown that the temperature profile of the plantar aspects of the foot provides a reliable warning of tissue injury and can be effectively used as a preventive modality. In this study we propose to further develop and clinically test a novel infrared-based temperature instrument (TempTouchRM®) that is intended for home use by high-risk diabetic patients. This step-on remote monitoring device will serve as an early warning system for impending ulcers and Charcot fractures. The study’s central hypothesis is that the TempTouchRM device will reduce the incidence of ulcers by providing an accurate, simple, and effective approach to monitor changes in foot temperatures.


Condition Intervention
Diabetes
Neuropathic Limb
Elevated Temperature
Shear Pressure
Increased Temperatures
Device: TempTouchRM
Device: Offloading

MedlinePlus related topics: Diabetes Foot Health
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: Novel Home Care Device for High-Risk Diabetic Patients

Further study details as provided by Diabetica Solutions Inc.:

Primary Outcome Measures:
  • incident foot ulcers [ Time Frame: one year ]

Secondary Outcome Measures:
  • temperature spikes on foot zones [ Time Frame: one year ]

Estimated Enrollment: 110
Study Start Date: January 2007
Estimated Study Completion Date: June 2008
Detailed Description:

The study’s central hypothesis is that the TempTouchRM device will reduce the incidence of ulcers by providing an accurate, simple, and effective approach to monitor changes in foot temperatures. To study this hypothesis, the following specific aims are proposed:

Aim 1: To develop, validate and implement software and protocols for the following: (i) data acquisition and processing, and (ii) the physician-TempTouchRM communications interface. A state-of-the-art web interface will be developed to allow clinicians to view the stored data for their patients.

Aim 2: To evaluate the effectiveness of the TempTouchRM in reducing the incidence of diabetic foot ulcers among high-risk patients. Our hypothesis is that patients monitored with the TempTouchRM will have fewer foot ulcers and that the ulcers will be less severe. The 110 patient study will comprise two treatment arms: the standard therapy group and the enhanced therapy group The latter will receive standard care plus infrared temperature monitoring using the TempTouchRM daily for 12 months. Elevated temperatures will provide information to the physician that prevention practices should be initiated, such as off-loading, skin care, etc.

Aim 3: To determine the normal range of temperature variations for each individual foot for patients in the Enhanced Therapy and to correlate deviations from this range to the incidence of ulcers. Our previous studies have used the contralateral foot as the control to detect abnormal temperatures. We will investigate the hypothesis that with proper trending of normal foot temperatures, the individual foot can serve as its own control for predicting ulcers.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diagnosis of diabetes by WHO criteria, ability to provide informed consent, 18-80 years of age.

Exclusion Criteria:

  • patients with open ulcers or open amputation sites, active Charcot arthropathy, severe peripheral vascular disease, active foot infection, dementia, impaired cognitive function, history of drug or alcohol abuse within one year of the study, or other conditions based on the PI’s clinical judgment.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00500175

Contacts
Contact: Kevin R HIggins, DPM (210) 657-2644 higgins@xilas.com
Contact: Ruben G Zamorano, MSW, MPH (210) 692-1114 ext 119 zamorano@xilas.com

Locations
United States, Texas
Kevin R. Higgins, DPM Recruiting
San Antonio, Texas, United States, 78217
Contact: Ruben G Zamorano, MSW, MPH     210-692-1114 ext 119     zamorano@xilas.com    
Sponsors and Collaborators
Diabetica Solutions Inc.
Investigators
Principal Investigator: Kevin R Higgins, DPM Unaffiliated
  More Information

Study ID Numbers: DK061815
Study First Received: July 10, 2007
Last Updated: July 11, 2007
ClinicalTrials.gov Identifier: NCT00500175  
Health Authority: United States: Institutional Review Board

Keywords provided by Diabetica Solutions Inc.:
diabetes
ulceration
amputation
pressure sores
shear friction

Study placed in the following topic categories:
Ulcer
Diabetes Mellitus
Pressure Ulcer

ClinicalTrials.gov processed this record on January 14, 2009